title: A cost-utility analysis of interferon beta for multiple sclerosis.
authors.affiliation: School of Health Sciences, University of Newcastle-upon-Tyne, UK.
authors.forename: D
authors.initials: D
authors.lastname: Parkin
authors.forename: P
authors.initials: P
authors.lastname: McNamee
authors.forename: A
authors.initials: A
authors.lastname: Jacoby
authors.forename: P
authors.initials: P
authors.lastname: Miller
authors.forename: S
authors.initials: S
authors.lastname: Thomas
authors.forename: D
authors.initials: D
authors.lastname: Bates
mesh_terms: D000276:Adjuvants, Immunologic / Q000191:economics* / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D016527:Drug Costs; D005260:Female; D006304:Health Status; D006801:Humans; D016899:Interferon-beta / Q000191:economics* / Q000627:therapeutic use; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D017059:Models, Econometric; D009103:Multiple Sclerosis / Q000188:drug therapy*; D017063:Outcome Assessment, Health Care; D019057:Quality-Adjusted Life Years; D006113:United Kingdom
chemical_list: D000276:Adjuvants, Immunologic; D016899:Interferon-beta